Target intelligence / Profile preview

AMPD2 antisense RNA 1 (AMPD2-AS1)

Target
AMPD2-AS1
Molecular classification
Other (long non-coding RNA)
01

Overview

AMPD2 antisense RNA 1 (AMPD2-AS1) is a long non-coding RNA (lncRNA) gene, not a protein, enzyme, transporter, or receptor[1]. Unlike AMPD2, which encodes a protein involved in purine metabolism, the function, molecular interactions, and clinical relevance of AMPD2-AS1 are currently poorly characterized in the scientific literature[1]. As a non-coding antisense RNA, it may have a regulatory role related to the expression of the AMPD2 gene or related pathways, but its function, disease associations, and potential as a therapeutic target remain undefined[1]. There is no evidence it is a therapeutic target, nor are there known drugs, biomarkers, or safety-related data. **Key context:** - The request appears to conflate AMPD2 (a well-studied enzyme and disease gene) with AMPD2-AS1, which is a non-coding RNA[1][3]. - AMPD2-AS1 is not a classic therapeutic target and is not functionally characterized as a receptor, enzyme, transporter, or similar class[1]. - Most resources (including GeneCards) list only sequence, genomic location, and basic transcript information for AMPD2-AS1, without biochemical data, interactors, or disease mechanisms[1]. If you are seeking information about the *protein-coding* gene AMPD2 (Adenosine monophosphate deaminase 2), which is involved in purine metabolism and disease, let me know and I can provide a fully structured answer for that protein target instead[3][4].

Other names
AMPD2 Antisense RNA 1AMPD2-AS1
02

Biological functions

Unknownpossible regulatory function (antisense RNA)
03

Disease associations

Unknown

Beyond the preview

Go deeper on AMPD2 antisense RNA 1 (AMPD2-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMPD2 antisense RNA 1 (AMPD2-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call